5241642025-07-012025-09-305241642025-09-305241642025-03-315241642025-04-012025-09-305241642025-07-012025-09-30in-capmkt:OtherExpenses1Member5241642025-04-012025-09-30in-capmkt:OtherExpenses1Member5241642025-07-012025-09-30in-capmkt:ReportableSegments1Member5241642025-07-012025-09-30in-capmkt:ReportableSegments2Member5241642025-07-012025-09-30in-capmkt:ReportableSegments3Member5241642025-04-012025-09-30in-capmkt:ReportableSegments1Member5241642025-04-012025-09-30in-capmkt:ReportableSegments2Member5241642025-04-012025-09-30in-capmkt:ReportableSegments3Member5241642025-07-012025-09-30in-capmkt:ReportableSegments1Member5241642025-07-012025-09-30in-capmkt:ReportableSegments2Member5241642025-07-012025-09-30in-capmkt:ReportableSegments3Member5241642025-04-012025-09-30in-capmkt:ReportableSegments1Member5241642025-04-012025-09-30in-capmkt:ReportableSegments2Member5241642025-04-012025-09-30in-capmkt:ReportableSegments3Member5241642025-07-012025-09-30in-capmkt:ReportableSegments1Member5241642025-09-30in-capmkt:ReportableSegments1Member5241642025-07-012025-09-30in-capmkt:ReportableSegments2Member5241642025-09-30in-capmkt:ReportableSegments2Member5241642025-07-012025-09-30in-capmkt:ReportableSegments3Member5241642025-09-30in-capmkt:ReportableSegments3Member5241642025-07-012025-09-30in-capmkt:ReportableSegments1Member5241642025-09-30in-capmkt:ReportableSegments1Member5241642025-07-012025-09-30in-capmkt:ReportableSegments2Member5241642025-09-30in-capmkt:ReportableSegments2Member5241642025-07-012025-09-30in-capmkt:ReportableSegments3Member5241642025-09-30in-capmkt:ReportableSegments3Member5241642025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15241642025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15241642025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15241642025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares524164IOLCPNOTLISTEDINE485C01029IOL Chemicals and pharmaceuticals limitedMain BoardEquity2025-04-012026-03-312025-11-112025-11-04INRCroresQuarterlySecond quarterMulti segment2025-11-1113:30:002025-11-1115:20:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated567530000068800000574410000036670000000147000006335000003480000019990000078930000053392000004049000000404900000896000001560000010520000002997000000000299700000390000030360000058710000021.021.02001.021.021.The aforesaid standalone and consolidated unaudited financial results for the quarter and half year ended 30th September 2025 were reviewed and recommended by the Audit Committee to the Board of Directors and subsequently approved by the Board of Directors at their respective meetings held on 11th November 2025. The said financial results have been subjected to a Limited Review by the Statutory Auditors of the Company, who have issued an unmodified report thereon. The financial results, along with the Auditor’s Report, are being filed with the National Stock Exchange of India Limited and BSE Limited and are also available on the Company’s website. <BR> <BR> 2.The financial results are prepared in accordance with the Indian Accounting Standards ("Ind AS") prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and are in compliance with the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements} Regulations, 2015. <BR> <BR> 3.As per Ind-AS 108 - Operating Segments, the Company has two reportable operating segments namely ‘Pharmaceuticals’ and ‘Chemicals’. The financial information for these segments has been provided in Financial Results. <BR> <BR> 4.The previous financial period figures have been regrouped/rearranged/restated, wherever considered necessary. <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated111922000001425000001133470000074325000000-10850000012100000007710000039760000014660000001047470000086000000008600000001945000002650000022100000006390000000000639000000-250000063650000058710000022.182.18002.182.18Other Expenses789300000Other Expenses1466000000112820000006448000000115900000236000001741000000341900000516000000142400000127247000003843400000345000005230900000273000000141000000007550000070239000005389000001140620000024130900000587100000169260000001751310000017513100000007460000080370000087830000015898000005010000035079000003558000000420400000556820000011690000022000000324000000573950000000661780000024130900000- Chemical2852300000- Pharmaceutical3363600000- Unallocated68700000- Chemical5662900000- Pharmaceutical6656900000- Unallocated1424000006284600000124622000005405000001127500000574410000011334700000- Chemical50500000- Pharmaceutical354500000- Unallocated0- Chemical109600000- Pharmaceutical755400000- Unallocated04050000008650000003480000077100000-34700000-72100000404900000860000000- Chemical5506700000- Pharmaceutical14159600000- Unallocated446460000024130900000024130900000- Chemical2024400000- Pharmaceutical1919800000- Unallocated267360000066178000000661780000077100000-237200000-33100000000000-73120000000039760000000000900000000000-6480000000-5907000002693000000001587000000110600000000000002000000646300000000000000000000000523000000-369600000-961600000000000004194000000007710000000342300000-5087000000-508700000781700000273000000Items that will not be reclassified to profit or loss72000007200000Items that will not be reclassified to profit or loss-11800000-118000001800000-3000000Items that will be reclassified to profit or loss-2000000-2000000Items that will be reclassified to profit or loss84000008400000-50000021000003900000-2500000